Income Not From Contract With Customer Cost Recovery Method
XOMA Corporation·Products & Services·2 segments·Rolls up to Income Not From Contract With Customer Cost Recovery Method
Breakdown
Segments
TovorafenibView metric
DsuviaView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Tovorafenib | $870K | $1.04M | $1.29M | $5.53M | $1.72M | $1.86M | $4.62M | $2.77M |
| Total | $870K | $1.04M | $1.29M | $5.53M | $1.74M | $1.86M | $4.62M | $2.77M |
Dsuvia is derived from annual filings.